Friday, July 28, 2006

Trials site aims to help pharma keep up with competitive intel

Trials site aims to help pharma keep up with competitive intel
A new searchable clinical trials database aims to help pharma, biotech, device, and diagnostic companies perform research and business development and gather competitive intelligence. The tool, from healthcare database firm DMS Data Systems, is available to subscribers at ClinicalTrialsPlus.com. It contains data from all of the clinical trials registered on clinicaltrials.gov, as well as access to archives of 240,000 related news stories and 5,000 company profiles. The site is updated daily and includes an e-mail alert system, powerful search features, and the ability to create PDF documents from search results, according to the company. Most clinical trial databases are intended for doctors or consumers, including one launched recently by the Center for Information & Study on Clinical Trial Participation.
 
buzz this

1 comments:

Danny Haszard said...

I took zyprexa which was ineffective for my condition and gave me diabetes.

Zyprexa, which is used for the treatment of psychiatric disorders, such as schizophrenia and bipolar disorder, accounted for 32% of Eli Lilly's $14.6 billion revenue last year.

Zyprexa is the product name for Olanzapine,it is Lilly's top selling drug.It was approved by the FDA in 1996 ,an 'atypical' antipsychotic a newer class of drugs without the motor side effects of the older Thorazine.Zyprexa has been linked to causing diabetes and pancreatitis.

Did you know that Lilly made nearly $3 billion last year on diabetic meds, Actos,Humulin and Byetta?

Yes! They sell a drug that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!

I was prescribed Zyprexa from 1996 until 2000.
In early 2000 i was shocked to have an A1C test result of 13.9 (normal is 4-6) I have no history of diabetes in my family.
----
Daniel Haszard http://www.zyprexa-victims.com